Biologics News
-
A*STAR & Duke-NUS unveils the map to design treatment for dengue and zika viruses
Biologics | News | 0 Comment | 24 Apr, 2019
Scientists from the Agency for Science, Technology and Research’s (A*STAR) Genome Institute of Singapore (GIS), together with scientists from Duke-NUS Medical School and A*STAR’...Read more
-
NUS researchers find new biomarkers associated with chemobrain
Biologics | News | 0 Comment | 24 Apr, 2019
Cognitive impairment associated with cancer, also known as “chemobrain”, has gained recognition as a complication of the disease and its treatment, as it can negatively affect t...Read more
-
NTU researchers link bronchiectasis with allergy
Biologics | News | 0 Comment | 22 Apr, 2019
An international research team led by Nanyang Technological University, Singapore (NTU Singapore) has found that patients with the lung disease bronchiectasis also often display sensitivity...Read more
-
India to be one of the world’s ‘fastest growing bio’ hubs in 2019: CPhI data
Biologics | News | 0 Comment | 18 Apr, 2019
New data from CPhI shows that, despite ongoing reputational challenges, India’s biologics market is set for robust growth in 2019 driven by biosimilars production. The India spe...Read more
-
Biologics | News | 0 Comment | 17 Apr, 2019
Investigations of 'quantum dots' for looking deeply into body tissues are rapidly evolving, but more work is required to ensure they are safe, according to a review published in the journal...Read more
-
NUS provides new insights into neuronal behaviour
Biologics | News | 0 Comment | 11 Apr, 2019
Dr Sajikumar Sreedharan and undergraduate student Karen Pang, PhD student Mahima Sharma, post-doctoral fellow Dr. Krishna Kumar – all from the Department of Physiology at the National...Read more
-
Researchers develop automated detection technique for eye surface cancer
Biologics | News | 0 Comment | 03 Apr, 2019
A team of researchers from the Centre for Nanoscale BioPhotonics (CNBP) in Australia has developed a new automated non-invasive technique for diagnosing eye surface cancer (ocular surface s...Read more
-
FDA approves ASCENIV for the treatment of primary humoral immunodeficiency disease
Biologics | News | 0 Comment | 02 Apr, 2019
ADMA Biologics, a vertically integrated commercial biopharmaceutical and specialty immunoglobulin company that manufactures, markets and develops plasma-derived biologics for the treat...Read more
-
GHIT selects joint research project on dengue by Chugai, A*STAR
Biologics | News | 0 Comment | 02 Apr, 2019
Chugai Pharmaceutical Co., Ltd. has announced that a joint research project between Chugai and the Agency for Science, Technology and Research, Singapore (A*STAR) since 2015 for an anti-den...Read more
-
Scientists identify FLIP Inhibitors for cancer treatment
Biologics | News | 0 Comment | 29 Mar, 2019
Queen’s University Belfast and Domainex are pleased to announce that their joint project team has successfully identified novel first-in-class small molecule inhibitors of the an...Read more
-
Duke-NUS study reveals new treatment option for liver cancer
Biologics | News | 0 Comment | 29 Mar, 2019
Researchers from Duke-NUS Medical School, Singapore General Hospital (SGH) and Lion TCR have demonstrated that they were able to engineer HBV-specific T cells, a type of immune cells found ...Read more
-
Duke-NUS study shows promise for heart muscle regeneration
Biologics | News | 0 Comment | 25 Mar, 2019
Researchers at Duke-NUS Medical School, Singapore, have developed an approach to regenerate heart muscle using stem cells. Their method for priming stem cells to become heart tissues could ...Read more
-
NUS researchers develop self-healing electronic skin
Biologics | News | 0 Comment | 22 Mar, 2019
Scientists from National University of Singapore (NUS) have taken inspiration from underwater invertebrates like jellyfish to create an electronic skin with similar functionality. Just lik...Read more
-
Fujifilm to acquire Biogen in a $890 M deal
Biologics | News | 0 Comment | 13 Mar, 2019
FUJIFILM Corporation ("Fujifilm") announced that it has entered into an agreement to acquire Biogen (Denmark) Manufacturing ApS, a large-scale biologics manufacturing site located in Hiller...Read more
-
Ambrx, BeiGene to develop next-generation biologics
Biologics | News | 0 Comment | 08 Mar, 2019
Ambrx Inc., a clinical-stage biopharmaceutical company focused on the development of innovative protein therapeutics and BeiGene, Ltd., a commercialstage biopharmaceutical company focused o...Read more
-
Study: Inflammation in the brain enhances the side-effects of hypnotic medication
Biologics | News | 0 Comment | 06 Mar, 2019
In a study recently published in the European Journal of Pharmacology researchers at Okayama University show how the presence of inflammation in the brain can increase its sensiti...Read more
-
Duke-NUS team reveals unknown mechanisms of zika infection
Biologics | News | 0 Comment | 05 Mar, 2019
Researchers at Duke-NUS Medical School and their colleagues have identified a surprising interaction between dengue and Zika viruses that sheds lights on the significant fetal brain abnorma...Read more
-
Data sharing uncovers five new risk genes for Alzheimer’s disease
Biologics | News | 0 Comment | 04 Mar, 2019
Analysis of genetic data from more than 94,000 individuals has revealed five new risk genes for Alzheimer’s disease, and confirmed 20 known others. An international team of researche...Read more
